https://doi.org/10.1016/j.celrep.2019.05.073
K
Kamlesh Bisht
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
1.1K
Citations
16
h-index
21
i10-index
Kamlesh Bisht is an academic researcher. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Immune Cell Function and Interaction & CAR-T cell therapy research. The author has an h-index of 16, co-authored 82 publications.
ORCID: 0009-0003-3808-924XPapers by this author
worksTwo Separation-of-Function Isoforms of Human TPP1 Dictate Telomerase Regulation in Somatic and Germ Cells
2019 · Cell Reports · 25 citations
Interaction of APC/C-E3 Ligase with Swi6/HP1 and Clr4/Suv39 in Heterochromatin Assembly in Fission Yeast
2009 · Journal of Biological Chemistry · 11 citations
https://doi.org/10.1074/jbc.m806461200
Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma
2024 · Cells · 11 citations
https://doi.org/10.3390/cells13100879
A lentivirus-free inducible CRISPR-Cas9 system for efficient targeting of human genes
2017 · Analytical Biochemistry · 6 citations
https://doi.org/10.1016/j.ab.2017.05.001
Outbreak of Respiratory Infection: nCoV-2019 Current Status and Its Impact on Global Health
2020 · Current Respiratory Medicine Reviews · 1 citations
https://doi.org/10.2174/1573398x16999201203162129
Supplementary Figure 4 from <i>Ex Vivo</i> Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies
2024 · 0 citations
https://doi.org/10.1158/2767-9764.25392855
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat